In April, Maryland approved the first-of-its-kind bill to create a board that will evaluate drug prices and set limits on how much state and local governments pay for high-cost prescription medications. The goal is to lower prescription drug-spending in the state.
After the board is established, it will study if the limits should be extended to private healthcare plans.
The governor and legislative leaders will appoint members to the board.
Read the full report here.
More articles on pharmacy:
Walmart cutting some pharmacy jobs
UPMC acquires community pharmacy in Pittsburgh
Oklahoma judge approves Teva’s $85M opioid settlement
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.